Page last updated: 2024-08-21

indazoles and Multiple Sclerosis

indazoles has been researched along with Multiple Sclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkinson, K; Karim, H; Katzenellenbogen, JA; Kim, SH; Lapato, AS; Lauderdale, K; Sekyi, M; Tiwari-Woodruff, SK; Yamate-Morgan, H; Yasui, N1
Atkinson, KC; Drew, A; Harris, NG; Hasselmann, JPC; Katzenellenbogen, JA; Kim, SH; Lee, JB; Obenaus, A; Soto, J; Tiwari-Woodruff, SK1
Al-Izki, S; Amor, S; Baker, D; Browne, L; Clutterbuck, L; Edith Chan, AW; Garthwaite, J; Gerritsen, WH; Giovannoni, G; Hankey, DJ; Joel, SP; Lidster, K; Montoya, A; Peferoen-Baert, R; Perkins, V; Posada, C; Pryce, G; Selwood, DL; Ummenthum, K; van der Valk, P; von Kutzleben, SM1
Carter, PH; Hynes, J1

Other Studies

4 other study(ies) available for indazoles and Multiple Sclerosis

ArticleYear
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis.
    Scientific reports, 2019, 01-24, Volume: 9, Issue:1

    Topics: Animals; Cell Proliferation; Cell Survival; Corpus Callosum; Cytokines; Estrogen Receptor beta; Female; Immunologic Factors; Indazoles; Ligands; Male; Mice; Multiple Sclerosis; Oligodendroglia; Remyelination

2019
Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis.
    Neurobiology of disease, 2019, Volume: 130

    Topics: Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Diffusion Tensor Imaging; Disease Models, Animal; Estrogen Receptor beta; Female; Indazoles; Magnetic Resonance Imaging; Male; Mice; Multiple Sclerosis; Neuroprotective Agents; Remyelination

2019
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Specimen Banks; Brain; Carbamazepine; Carrier Proteins; Cell Proliferation; Chromatography, High Pressure Liquid; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Indazoles; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; Optic Neuritis; Oxadiazoles; Sodium Channel Blockers; T-Lymphocytes; Uveitis; Voltage-Gated Sodium Channels

2014
N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Expert opinion on therapeutic patents, 2010, Volume: 20, Issue:11

    Topics: Animals; Arthritis, Rheumatoid; Calcium; Disease Models, Animal; Humans; Indazoles; Inflammation; Leukocytes; Multiple Sclerosis; Patents as Topic; Pyrazoles; Receptors, CCR1; Structure-Activity Relationship

2010